Role of cardiac magnetic resonance imaging in ischaemic heart disease

Internal Medicine Journal

Volumn 39, Issue 9, 2009, Pages 563-573

  Wright, J ^a,b   Bogaert, J ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b GREENSLOPES PRIVATE HOSPITAL   (Australia)

Author keywords

Cardiac magnetic resonance imaging; Ischaemic heart disease

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM; GADOLINIUM PENTETATE; GADOTERIC ACID; IODINATED CONTRAST MEDIUM;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; CARDIOMYOPATHY; CHRONIC DISEASE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIFFUSION WEIGHTED IMAGING; DRUG ACCUMULATION; DRUG TISSUE LEVEL; HEART FUNCTION TEST; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY DYSFUNCTION; MORPHOLOGY; NEPHROGENIC SYSTEMIC FIBROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; UNSPECIFIED SIDE EFFECT;

ANIMALS; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MYOCARDIAL ISCHEMIA;

EID: 70349303118     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2008.01884.x     Document Type: Review

References (27)

1. Bogaert J, Bosmans H, Rademakers FE, Bellon EP, Herregods MC, Verschakelen JA et al. Left ventricular quantification with breath-hold MR imaging: comparison with echocardiography. MAGMA 1995 3 : 5 12.
2. Sakuma H, Fujita N, Foo TK, Caputo GR, Nelson SJ, Hartiala J et al. Evaluation of left ventricular volume and mass with breath-hold cine MR imaging. Radiology 1993 188 : 377 380.
3. Grothues F, Smith GC, Moon JC, Bellenger NG, Collins P, Klein HU et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure of left ventricular hypertrophy. Am J Cardiol 2002 90 : 29 34.
4. Kozerke S, Schwitter J, Pedersen EM, Boesiger P. Aortic and mitral regurgitation: quantification using moving slice velocity mapping. J Magn Reson Imaging 2001 14 : 106 112.
5. Eichenberger AC, Jenni R, von Schulthess GK. Aortic valve pressure gradients in patients with aortic valve stenosis: quantification with velocity-encoded cine MR imaging. Am J Roentgenol 1993 160 : 971 977.
6. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999 100 : 1992 2002.
7. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim R. Visualization of presence, location, and transmural extent of healed Q-wave and non-Q wave myocardial infarction. Lancet 2001 357 : 21 8.
8. Wagner A, Mahrholdt H, Holly TA, Elliot MD, Regenfus M, Parker M et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial defects: an imaging study. Lancet 2003 361 : 374 379.
9. Reimer KA, Jennings RB. The 'wavefront phenomenon' of myocardial ischaemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest 1979 40 : 633 644.
10. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med 2007 357 : 1121 1135.
11. Kim YW, Danias PG, Stuber M, Flamm SD, Plein S, Nagel E et al. Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med 2001 345 : 1863 1869. (Pubitemid 33716560)
12. Sakuma H, Ichikawa Y, Chino S, Hirano T, Makino K, Takeda K. Detection of coronary artery stenosis with whole-heart coronary magnetic resonance angiography. J Am Coll Cardiol 2006 48 : 1946 1950.
13. Nandalur KR, Dwamena BA, Choudhri AF, Nandalur MR, Carlos RC. Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease. J Am Coll Cardiol 2007 50 : 1343 1353.
14. Wahl A, Paetsch I, Gollesch A, Roethemeyer S, Foell D, Gebker R et al. Safety and feasibility of high-dose dobutamine-atropine stress MRI for diagnosis of myocardial ischaemia: experience in 1000 consecutive cases. Eur Heart J 2004 25 : 1230 1236.
15. Schwitter J, Wacker CM, van Rossum AC, Lombardi M, Al-Saadi N, Ahlstrom H et al. MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J 2008 29 : 480 489.
16. Panting JR, Gatehouse PD, Yang GZ, Grothues F, Firmin DN, Collins P et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 2002 346 : 1948 1953.
17. Jahnke C, Nage E, Gebker R, Kokocinski T, Kelle S, Manka R et al. Prognostic value of cardiac magnetic resonance stress tests. Adenosine stress perfusion and Dobutamine stress wall motion imaging. Circulation 2007 115 : 1769 1776.
18. Friedrich MG, Abdel-Aty H, Taylor A, Schulz-Menger J, Messroghli D, Dietz R. The salvaged area at risk in reperfused acute myocardial infarction as visualised by cardiovascular magnetic resonance. J Am Coll Cardiol 2008 51 : 1581 1587.
19. De Roos A, Van Rossum AC, van der Wall E, Postema S, Doornbos J, Matheijssen N et al. Reperfused and nonreperfused myocardial infarction: diagnostic potential of Gd-DTPA-enhanced MR imaging. Radiology 1989 172 : 717 720.
20. Srichai MB, Junor C, Rodriquez LL, Stillman AE, Grimm RA, Lieber ML et al. Clinical, imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrast-enhanced magnetic resonance imaging, transthoracic-echocardiography, and transesophageal echocardiography with surgical or pathological validation. Am Heart J 2006 152 : 75 84.
21. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002 39 : 1151 1158.
22. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000 343 : 1445 1453.
23. Wellnhofer E, Olariu A, Klein C, Grafe M, Wahl A, Fleck E et al. Magnetic resonance low-dose dobutamine test is superior to scar quantification for the prediction of functional recovery. Circulation 2004 109 : 2172 2174.
24. Schinkel AF, Bax JJ, Poldermans D, Elhendy A, Ferrari R, Rahimtoola SH. Hibernating myocardium: Diagnosis and Patient Outcomes. Curr Probl Cardiol 2007 32 : 375 410.
25. Hendel RC, Patel MR, Kramer CM, Poon M. ACCF/ACR/SCCT/SCMR/ASNC/NASCI/ SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation/American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol 2006 48 : 1475 1497.
26. Pennell DJ, Sechtem UP, Higgins CB, Manning WJ, Pohost GM, Rademakers FE et al. Clinical indications for cardiovascular magnetic resonance (CMR): consensus panel report. Eur Heart J 2004 25 : 1940 1965.
27. Kramer CM, Budoff MJ, Fayad ZA, Ferrari VA, Goldman C, Lesser JR et al. ACCF/AHA clinical competence statement on vascular imaging with computed tomography and magnetic resonance: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training. J Am Coll Cardiol 2007 50 : 1097 1114.